| Literature DB >> 35148347 |
Rachel E Guetta1,2, Clair Cassiello-Robbins1, Jacqueline Trumbull1,2, Deepika Anand1, M Zachary Rosenthal1,2.
Abstract
Misophonia is a newly described condition characterized by sensory and emotional reactivity (e.g., anxiety, anger, disgust) to repetitive, pattern-based sounds (e.g., throat clearing, chewing, slurping). Individuals with misophonia report significant functional impairment and interpersonal distress. Growing research indicates ineffective coping and emotional functioning broadly (e.g., affective lability, difficulties with emotion regulation) are central to the clinical presentation and severity of misophonia. Preliminary evidence suggests an association between negative emotionality and deficits in emotion regulation in misophonia. Still, little is known about (a) the relationships among specific components of emotional functioning (e.g., emotion regulation, affective lability) with misophonia, and (b) which component(s) of misophonia (e.g., noise frequency, emotional and behavioral responses, impairment) are associated with emotional functioning. Further, despite evidence that mood and anxiety disorders co-occur with misophonia, investigation thus far has not controlled for depression and anxiety symptoms. Examination of these relationships will help inform treatment development for misophonia. The present study begins to disambiguate the relationships among affective lability, difficulties with emotion regulation, and components of misophonia. A sample of 297 participants completed questionnaires assessing misophonia, emotional functioning, depression, anxiety, and COVID-19 impact. Findings indicated that misophonia severity was positively associated with each of these constructs with small to medium effect sizes. When controlling for depression, anxiety, and COVID-19 impact, results from this preliminary study suggest that (a) difficulties with emotion regulation may be correlated with misophonia severity, and (b) misophonic responses, not number of triggers or perceived severity, are associated with difficulties with emotion regulation. Overall, these findings begin to suggest that emotion regulation is important to our understanding the risk factors and treatment targets for misophonia.Entities:
Mesh:
Year: 2022 PMID: 35148347 PMCID: PMC8836307 DOI: 10.1371/journal.pone.0263230
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographics and sample characteristics.
| Variable |
| N (%) |
|---|---|---|
| Age | 39.13 (11.52) | |
| Male | 156 (52.5) | |
| Female | 141 (47.5) | |
| Race | ||
| White | 247 (83.2) | |
| Black or African-American | 21 (7.1) | |
| Other Asian or Other Asian American (includes India, Malaysia, Pakistan, Philippines) | 10 (3.4) | |
| More Than One Racial Group | 6 (2.0) | |
| Korean or Korean American | 6 (2.0) | |
| Other | 3 (1.0) | |
| Chinese or Chinese American | 2 (0.7) | |
| Japanese or Japanese American | 1 (0.3) | |
| Native American, American Indian, Alaska Native | 1 (0.3) | |
| Ethnicity | ||
| Hispanic | 19 (6.4) | |
| Non-Hispanic | 278 (93.6) | |
| Education Level | ||
| Some High School | 1 (0.3) | |
| GED | 10 (3.4) | |
| High School Graduate | 28 (9.4) | |
| Bus/Tech Training Beyond High School | 12 (4.0) | |
| Some College | 79 (26.6) | |
| College Graduate | 120 (40.4) | |
| Some Graduate School | 7 (2.4) | |
| Masters Degree | 35 (11.8) | |
| Doctoral Degree | 5 (1.7) | |
| Household Income | ||
| 0 - $10,000 | 26 (8.8) | |
| $10,000 - $20,000 | 29 (9.8) | |
| $20,001 - $40,000 | 70 (23.6) | |
| $40,001 –$65,000 | 63 (21.2) | |
| $65,001 - $100,000 | 56 (18.9) | |
| More than $100,000 | 53 (17.8) | |
| MQ Symptom Subscale | 1.30 (.87) | |
| MQ Emotions and Behaviors Subscale | 0.93 (.61) | |
| MQ Severity Rating | 3.63 (2.51) | |
| DERS_SF Total Score | 35.43 (13.61) | |
| ALS-18 Total Score | 40.63 (14.46) | |
| GAD-7 Total Score | 4.35 (4.73) | |
| PHQ-9 Total Score | 4.35 (5.14) | |
| CEFIS | 6.78 (2.87) |
Note. MQ = Misophonia Questionnaire; DERS-SF = Difficulties with Emotion Regulation Scale Short Form; ALS-18 = Affective Lability Scale; GAD-7 = Generalized Anxiety Disorder 7-Item Scale; PHQ-9 = Patient Health Questionnaire; CEFIS = COVID-19 Exposure and Family Impact Survey.
Bivariate correlations between measures of misophonia, difficulties with emotion regulation, affective lability, COVID-19 impact, anxiety, and depression.
| Variable | DERS-SF | ALS-18 | CEFIS | GAD-7 | PHQ-9 |
|---|---|---|---|---|---|
| MQ Total Score | .45 | -.16 | .30 | .43 | .42 |
Note.
**p < .01, N = 265, Correlations used logarithmically transformed variables as indicated in text. MQ = Misophonia Questionnaire; DERS-SF = Difficulties with Emotion Regulation Scale Short Form; ALS-18 = Affective Lability Scale; CEFIS = COVID-19 Exposure and Family Impact Survey; GAD-7 = Generalized Anxiety Disorder 7-Item Scale; PHQ-9 = Patient Health Questionnaire.
Multiple linear regressions examining emotional functioning in misophonia.
| Dependent Variable | Variables | β unstd. | SE | β std | p | R2 | R2 | |
|---|---|---|---|---|---|---|---|---|
| MQ composite severity | Step 1 | Age | .01 | .01 | .04 | .520 | .24 | .24 |
| Gender | .03 | .18 | .01 | .870 | ||||
|
| 1.43 | .49 | .26 | .004 | ||||
|
| .97 | .47 | .18 | .040 | ||||
|
| .13 | .05 | .16 | .005 | ||||
| Step 2 | Age | .01 | .01 | .06 | .280 | .28 | .04 | |
| Gender | .09 | .18 | .03 | .602 | ||||
|
| 1.07 | .48 | .19 | .028 | ||||
| PHQ-9 | .31 | .49 | .06 | .523 | ||||
|
| .13 | .04 | .17 | .003 | ||||
|
| 3.96 | 1.07 | .26 | < .0001 | ||||
| ALS-18 | -.29 | .44 | -.04 | .520 | ||||
| DERS-SF total | Step 1 |
| .00 | .00 | -.11 | .023 | .44 | .44 |
| Gender | -.02 | .01 | -.08 | .107 | ||||
|
| .09 | .03 | .24 | .002 | ||||
|
| .16 | .03 | .46 | < .0001 | ||||
| CEFIS | .00 | .00 | -.04 | .457 | ||||
| Step 2 | Age | .00 | .00 | -.09 | .058 | .51 | .07 | |
| Gender | -.02 | .01 | -.07 | .112 | ||||
|
| .07 | .03 | .18 | .016 | ||||
|
| .13 | .03 | .37 | < .0001 | ||||
| CEFIS | .00 | .00 | -.06 | .203 | ||||
|
| .10 | .02 | .40 | < .0001 | ||||
| MQ Symptoms | -.02 | .01 | -.09 | .097 | ||||
| MQ Impairment | .00 | .00 | -.07 | .259 |
Note. Variables with p-values less than .05 are shown in bold. MQ = Misophonia Questionnaire; GAD-7 = Generalized Anxiety Disorder 7-item scale; PHQ-9 = The Patient Health Questionnaire; CEFIS = The COVID-19 Exposure and Family Impact Survey; DERS-SF = Difficulties in Emotion Regulation Scale–Short Form; ALS-18 = Affective Lability Scale– 18 Item.